Key result
Novel patient-derived iPSC line successfully models autosomal dominant diabetes with ZYG11A and GATA6 mutations.
Answers are grounded in this paper and cite their sources.
Reports the generation of a patient-derived stem cell line carrying ZYG11A and GATA6 mutations, highlighting a new cellular model for studying autosomal dominant diabetes.
Two heterozygous mutations (p.L475P in ZYG11A and p.E51K in GATA6) were identified in a family with autosomal dominant diabetes. ZYG11A-p.L475P was proposed as a causative mutation because of the complete segregation with hyperglycemia and the proven pathogenic effect on beta-cell expansion. The modifying effect of GATA6-p.E51K was proposed owing to the earlier onset of the carriers. Herein, we establish a line of induced pluripotent stem cells (iPSCs) from peripheral blood mononuclear cells (PBMCs) of a proband who carries both mutations using Sendai viral vectors. The generated iPSC line was characterized for pluripotency, chromosomal normality, and authentication.
No takes yet. Share an insight, caveat, or question.
Suwanpitak et al. (2022) studied Autosomal dominant diabetes (n=1). Sendai viral vectors for iPSC generation was evaluated on Characterization of generated iPSC line for pluripotency, chromosomal normality, and authentication. An induced pluripotent stem cell line was successfully generated and characterized from a patient with autosomal dominant diabetes carrying ZYG11A and GATA6 mutations.
Synapse has enriched 10 related papers. Consider them for comparative context: